http://www.miaminewtimes.com/2013-01-31 ... ames/full/Although A-Rod is the biggest name in Tony Bosch's records, he's far from alone. Melky Cabrera is mentioned 14 times throughout. A switch-hitting outfielder from the Dominican Republic, Cabrera had enjoyed a steady but fairly middle-of-the-road career until signing with the San Francisco Giants last year. Suddenly, he began pounding the baseball, whacking a team record 51 hits in May alone. Three months later, he nabbed more votes than any outfielder for the All-Star Game and won the game MVP after going two for three at the dish.
Cabrera's dream season screeched to a halt in August, though, when MLB announced a 50-game suspension after his blood tested positive for elevated levels of testosterone. Cabrera quickly admitted he'd used a banned substance and didn't fight the suspension. But what substance did he take?
It might be what's listed in a 2012 notebook from Bosch's office. Under a heading labeled "Melkys/Mostro," Bosch writes, "April 4th drop off, has enough meds until May 4... next visit deliver and infuse $9,000 to RPO and $900 exp. and charges. Call him for expense. Missing this mo. troches and pink cream."
Another document in the files, labeled simply "Mostro" — his nickname for Cabrera — and dated December 21, 2011, lists his regimen: a cocktail of drugs including IGF-1.
(There's also an odd, handwritten letter by Bosch in his notebook that seems to refer to Cabrera's suspension for elevated testosterone. Addressed to a "Juan," Bosch rails against Cabrera, writing that "in helping him, I put my business and all my doctors at risk by fabricating patient charts and phony prescriptions." He adds that the slugger should "man-up" and pay $9,000 he owes, adding, "I am on the 'line' here!!")
Indeed, there are two patterns to the names of athletes in Bosch's records: (1) Most have direct ties to Miami and often to the UM Hurricanes baseball program, and (2) a number have already been caught doping — which suggests that either Bosch isn't particularly gifted at crafting drugs that can beat performance tests or his clients aren't careful.